Alessandra Mecozzi

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Maria Carmela Piccirillo, Paolo A. Ascierto, Carlo Salvarani et al. · Journal of Translational Medicine · 2020 · 112 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach

Andrea Marcellusi, Raffaella Viti, Alessandra Mecozzi et al. · The European Journal of Health Economics · 2014 · 70 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +14

Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?

Valeria Belvisi, Cosmo Del Borgo, Serena Vita et al. · Journal of Hospital Infection · 2020 · 29 citations · Full text

Life Sciences, Infectious Disease Control, Infectious Diseases +17

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

Simone Lanini, Paola Scognamiglio, Alessandra Mecozzi et al. · BMC Infectious Diseases · 2018 · 27 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +15

Comparative effectiveness and safety of erythropoiesis-stimulating agents (biosimilars vs originators) in clinical practice: a population-based cohort study in Italy

Francesco Trotta, Valeria Belleudi, Danilo Fusco et al. · BMJ Open · 2017 · 26 citations · Full text

Pharmacy, Pharmacotherapy, Comparative Effectiveness Research +14